Can pulmonary vasodilator therapy expand the operative indications for congenital heart disease?

International Heart Journal
Kei Inai

Abstract

The operability of congenital heart disease with left to right shunt depends on the severity of the pulmonary vascular disease induced by the increased pulmonary blood flow. Although some recommendations exist regarding operative indications according to pathological, hemodynamic, and epidemiological factors, the evidence underlying these recommendations is not conclusive. Recently, oral pulmonary vasodilator therapy has been reported to improve outcomes in patients with idiopathic pulmonary arterial hypertension, and this therapy also appears to be effective in patients with congenital heart disease and pulmonary arterial hypertension, including those with postoperative pulmonary hypertension and Eisenmenger syndrome. It is expected that the availability of novel pulmonary vasodilator therapy will expand the operative indications in patients with congenital heart disease with left to right shunt, but there is currently insufficient evidence to definitively determine this. A multicenter double-blind study should be conducted to further examine this issue.

References

Jan 1, 1974·Advances in Cardiology·W H Weidman, J W DuShane
Jan 1, 1973·The American Journal of Cardiology·K S DaveM I Ionescu
Jan 1, 1970·Cardiovascular Research·C G LaFarge, O S Miettinen
Jul 1, 1968·Circulation·S H RahimtoolaH B Burchell
Dec 1, 1981·The Thoracic and Cardiovascular Surgeon·H M HoffmeisterH E Hoffmeister
Jul 1, 1996·Pediatric Cardiology·B P LundellC G Wallgren
Mar 5, 2003·The American Journal of Cardiology·Susan M FernandesMichael J Landzberg
Jul 1, 1963·The American Journal of Cardiology·J W KIRKLIN, J W DUSHANE
Mar 23, 2004·European Heart Journal·Ghada W MikhailMichael A Gatzoulis
Jul 31, 2007·International Journal of Cardiology·Michael A GatzoulisUNKNOWN BREATHE-5 Investigators
Sep 27, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Astrid E LammersRobert Yates
Dec 19, 2007·Journal of Interventional Cardiology·Leonhard BruchFranz X Kleber
Feb 28, 2009·Journal of the American College of Cardiology·Maurice Beghetti, Nazzareno Galiè
Mar 5, 2009·The Journal of Thoracic and Cardiovascular Surgery·Konrad HoetzeneckerIrene M Lang
Apr 27, 2010·The Annals of Thoracic Surgery·Young-Hwue KimIn-Sook Park
Sep 30, 2010·Revista española de cardiología·Maurice Beghetti, Cecile Tissot
Dec 2, 2010·European Respiratory Review : an Official Journal of the European Respiratory Society·R L Cordina, D S Celermajer
Dec 2, 2010·European Respiratory Review : an Official Journal of the European Respiratory Society·B J M Mulder
Jul 23, 2011·Journal of the American College of Cardiology·Boris S LoweAriane J Marelli
Sep 29, 2011·The American Journal of Cardiology·Oliver MonfrediVaikom S Mahadevan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.